These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

316 related items for PubMed ID: 12866378

  • 1. Expression of caveolin-1 and caveolin-2 in urothelial carcinoma of the urinary bladder correlates with tumor grade and squamous differentiation.
    Fong A, Garcia E, Gwynn L, Lisanti MP, Fazzari MJ, Li M.
    Am J Clin Pathol; 2003 Jul; 120(1):93-100. PubMed ID: 12866378
    [Abstract] [Full Text] [Related]

  • 2. Noninvasive squamous lesions in the urinary bladder: a clinicopathologic analysis of 29 cases.
    Guo CC, Fine SW, Epstein JI.
    Am J Surg Pathol; 2006 Jul; 30(7):883-91. PubMed ID: 16819332
    [Abstract] [Full Text] [Related]

  • 3. PD-L1 (B7-H1) expression by urothelial carcinoma of the bladder and BCG-induced granulomata: associations with localized stage progression.
    Inman BA, Sebo TJ, Frigola X, Dong H, Bergstralh EJ, Frank I, Fradet Y, Lacombe L, Kwon ED.
    Cancer; 2007 Apr 15; 109(8):1499-505. PubMed ID: 17340590
    [Abstract] [Full Text] [Related]

  • 4. Cyclooxygenase-2 expression on urothelial and inflammatory cells of cystoscopic biopsies and urine cytology as a possible predictive marker for bladder carcinoma.
    Moussa M, Omran Z, Nosseir M, Lotfy A, Swellam T.
    APMIS; 2009 Jan 15; 117(1):45-52. PubMed ID: 19161536
    [Abstract] [Full Text] [Related]

  • 5. Invasive micropapillary urothelial carcinoma of the bladder.
    Lopez-Beltran A, Montironi R, Blanca A, Cheng L.
    Hum Pathol; 2010 Aug 15; 41(8):1159-64. PubMed ID: 20381120
    [Abstract] [Full Text] [Related]

  • 6. Transient receptor potential vanilloid type 2 (TRPV2) expression in normal urothelium and in urothelial carcinoma of human bladder: correlation with the pathologic stage.
    Caprodossi S, Lucciarini R, Amantini C, Nabissi M, Canesin G, Ballarini P, Di Spilimbergo A, Cardarelli MA, Servi L, Mammana G, Santoni G.
    Eur Urol; 2008 Sep 15; 54(3):612-20. PubMed ID: 17977643
    [Abstract] [Full Text] [Related]

  • 7. Minichromosome maintenance proteins 2 and 5 expression in muscle-invasive urothelial cancer: a multivariate survival study including proliferation markers and cell cycle regulators.
    Korkolopoulou P, Givalos N, Saetta A, Goudopoulou A, Gakiopoulou H, Thymara I, Thomas-Tsagli E, Patsouris E.
    Hum Pathol; 2005 Aug 15; 36(8):899-907. PubMed ID: 16112007
    [Abstract] [Full Text] [Related]

  • 8. Prognostic value of EGF receptor and tumor cell proliferation in bladder cancer: therapeutic implications.
    Popov Z, Gil-Diez-De-Medina S, Ravery V, Hoznek A, Bastuji-Garin S, Lefrere-Belda MA, Abbou CC, Chopin DK.
    Urol Oncol; 2004 Aug 15; 22(2):93-101. PubMed ID: 15082004
    [Abstract] [Full Text] [Related]

  • 9. Detection of residual tumor cells in bladder biopsy specimens: pitfalls in the interpretation of cytokeratin stains.
    Tamas EF, Epstein JI.
    Am J Surg Pathol; 2007 Mar 15; 31(3):390-7. PubMed ID: 17325480
    [Abstract] [Full Text] [Related]

  • 10. Prognostic impact of p63 and p53 expression in upper urinary tract transitional cell carcinoma.
    Zigeuner R, Tsybrovskyy O, Ratschek M, Rehak P, Lipsky K, Langner C.
    Urology; 2004 Jun 15; 63(6):1079-83. PubMed ID: 15183954
    [Abstract] [Full Text] [Related]

  • 11. Epidermal growth factor receptor, MUC-1 and MUC-2 in bladder cancer.
    Cardillo MR, Castagna G, Memeo L, De Bernardinis E, Di Silverio F.
    J Exp Clin Cancer Res; 2000 Jun 15; 19(2):225-33. PubMed ID: 10965823
    [Abstract] [Full Text] [Related]

  • 12. Transitional cell carcinomas and nonurothelial carcinomas of the urinary bladder differ in the promoter methylation status of the caveolin-1, hDAB2IP and p53 genes, but not in the global methylation of Alu elements.
    Kunze E, Von Bonin F, Werner C, Wendt M, Schlott T.
    Int J Mol Med; 2006 Jan 15; 17(1):3-13. PubMed ID: 16328005
    [Abstract] [Full Text] [Related]

  • 13. Synchronous squamous cell carcinoma of the kidney, squamous cell carcinoma of the ureter, and sarcomatoid carcinoma of the urinary bladder: a case report.
    Terada T.
    Pathol Res Pract; 2010 Jun 15; 206(6):379-83. PubMed ID: 19766408
    [Abstract] [Full Text] [Related]

  • 14. Association of TSC1/hamartin, 14-3-3sigma, and p27 expression with tumor outcomes in patients with pTa/pT1 urothelial bladder carcinoma.
    Mhawech-Fauceglia P, Alvarez V, Fischer G, Beck A, Herrmann FR.
    Am J Clin Pathol; 2008 Jun 15; 129(6):918-23. PubMed ID: 18480009
    [Abstract] [Full Text] [Related]

  • 15. Hypoxia-inducible factor-1alpha expression correlates with focal macrophage infiltration, angiogenesis and unfavourable prognosis in urothelial carcinoma.
    Chai CY, Chen WT, Hung WC, Kang WY, Huang YC, Su YC, Yang CH.
    J Clin Pathol; 2008 May 15; 61(5):658-64. PubMed ID: 17908805
    [Abstract] [Full Text] [Related]

  • 16. CIS is a surrogate marker of genetic instability and field carcinogenesis in the urothelial mucosa.
    Palmeira C, Lameiras C, Amaro T, Lima L, Koch A, Lopes C, Oliveira PA, Santos L.
    Urol Oncol; 2011 May 15; 29(2):205-11. PubMed ID: 19854077
    [Abstract] [Full Text] [Related]

  • 17. [Correlation of clusterin expression to prognosis of bladder carcinoma].
    Luo JH, Xie D, Chen W, Dai YP, Li XF, Tao Y, Zheng KL.
    Ai Zheng; 2005 Jun 15; 24(6):743-7. PubMed ID: 15946493
    [Abstract] [Full Text] [Related]

  • 18. Proteomics and immunohistochemistry define some of the steps involved in the squamous differentiation of the bladder transitional epithelium: a novel strategy for identifying metaplastic lesions.
    Celis JE, Celis P, Ostergaard M, Basse B, Lauridsen JB, Ratz G, Rasmussen HH, Orntoft TF, Hein B, Wolf H, Celis A.
    Cancer Res; 1999 Jun 15; 59(12):3003-9. PubMed ID: 10383167
    [Abstract] [Full Text] [Related]

  • 19. Correlation between sigma2 receptor protein expression and histopathologic grade in human bladder cancer.
    Colabufo NA, Berardi F, Contino M, Ferorelli S, Niso M, Perrone R, Pagliarulo A, Saponaro P, Pagliarulo V.
    Cancer Lett; 2006 Jun 08; 237(1):83-8. PubMed ID: 16005143
    [Abstract] [Full Text] [Related]

  • 20. Decreased DOC-2/DAB2 expression in urothelial carcinoma of the bladder.
    Karam JA, Shariat SF, Huang HY, Pong RC, Ashfaq R, Shapiro E, Lotan Y, Sagalowsky AI, Wu XR, Hsieh JT.
    Clin Cancer Res; 2007 Aug 01; 13(15 Pt 1):4400-6. PubMed ID: 17671122
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.